Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgitte Holst

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
Cell Reports. Medicine|May 2, 2022
LEAP2 reduces postprandial glucose excursions and <i>ad libitum</i> food intake in healthy menChristoffer A Hagemann, Malene S Jensen, Stephanie Holm, et al.
Neuroendocrinology|December 17, 2020
Estrous Cycle Modulation of Feeding and Relaxin-3/Rxfp3 mRNA Expression: Implications for Estradiol ActionCamila de Ávila, Sandrine Chometton, Juliane Calvez, et al.
Endocrinology|March 30, 2022
Beta-Hydroxybutyrate Suppresses Hepatic Production of the Ghrelin Receptor Antagonist LEAP2Stephanie Holm, Anna S Husted, Louise J Skov, et al.
Diabetes|April 3, 2019
Long-Acting Neurotensin Synergizes With Liraglutide to Reverse Obesity Through a Melanocortin-Dependent PathwayCecilia Ratner, Zhenyan He, Kaare V Grunddal, et al.
Journal of Medical Genetics|April 13, 2016
Functional and genetic epidemiological characterisation of the FFAR4 (GPR120) p.R270H variant in the Danish populationMarie A Vestmar, Ehm A Andersson, Charlotte R Christensen, et al.
Cell Metabolism|December 3, 2014
The melanocortin-4 receptor is expressed in enteroendocrine L cells and regulates the release of peptide YY and glucagon-like peptide 1 in vivoBrandon L Panaro, Iain R Tough, Maja S Engelstoft, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 11, 2023
Initial Pharmacological Characterization of a Major Hydroxy Metabolite of PF-5190457: Inverse Agonist Activity of PF-6870961 at the Ghrelin ReceptorSara L Deschaine, Morten A Hedegaard, Claire L Pince, et al.
Endocrinology|August 7, 2012
Acylation type determines ghrelin's effects on energy homeostasis in rodentsKristy M Heppner, Nilika Chaudhary, Timo D Müller, et al.
Diabetes|March 5, 2010
MTNR1B G24E variant associates With BMI and fasting plasma glucose in the general population in studies of 22,142 EuropeansEhm A Andersson, Birgitte Holst, Thomas Sparsø, et al.
Endocrinology|February 14, 2009
G protein-coupled receptor 39 deficiency is associated with pancreatic islet dysfunctionBirgitte Holst, Kristoffer L Egerod, Chunyu Jin, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Cell Reports. Medicine|May 2, 2022
LEAP2 reduces postprandial glucose excursions and <i>ad libitum</i> food intake in healthy menChristoffer A Hagemann, Malene S Jensen, Stephanie Holm, et al.
Neuroendocrinology|December 17, 2020
Estrous Cycle Modulation of Feeding and Relaxin-3/Rxfp3 mRNA Expression: Implications for Estradiol ActionCamila de Ávila, Sandrine Chometton, Juliane Calvez, et al.
Endocrinology|March 30, 2022
Beta-Hydroxybutyrate Suppresses Hepatic Production of the Ghrelin Receptor Antagonist LEAP2Stephanie Holm, Anna S Husted, Louise J Skov, et al.
Diabetes|April 3, 2019
Long-Acting Neurotensin Synergizes With Liraglutide to Reverse Obesity Through a Melanocortin-Dependent PathwayCecilia Ratner, Zhenyan He, Kaare V Grunddal, et al.
Journal of Medical Genetics|April 13, 2016
Functional and genetic epidemiological characterisation of the FFAR4 (GPR120) p.R270H variant in the Danish populationMarie A Vestmar, Ehm A Andersson, Charlotte R Christensen, et al.
Cell Metabolism|December 3, 2014
The melanocortin-4 receptor is expressed in enteroendocrine L cells and regulates the release of peptide YY and glucagon-like peptide 1 in vivoBrandon L Panaro, Iain R Tough, Maja S Engelstoft, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 11, 2023
Initial Pharmacological Characterization of a Major Hydroxy Metabolite of PF-5190457: Inverse Agonist Activity of PF-6870961 at the Ghrelin ReceptorSara L Deschaine, Morten A Hedegaard, Claire L Pince, et al.
Endocrinology|August 7, 2012
Acylation type determines ghrelin's effects on energy homeostasis in rodentsKristy M Heppner, Nilika Chaudhary, Timo D Müller, et al.
Diabetes|March 5, 2010
MTNR1B G24E variant associates With BMI and fasting plasma glucose in the general population in studies of 22,142 EuropeansEhm A Andersson, Birgitte Holst, Thomas Sparsø, et al.
Endocrinology|February 14, 2009
G protein-coupled receptor 39 deficiency is associated with pancreatic islet dysfunctionBirgitte Holst, Kristoffer L Egerod, Chunyu Jin, et al.
Pageof 13